You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Suppressor Cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metabolic & Bariatric Surgery on Lipid Metabolism,

Not yet recruiting
  • Obesity
  • Metabolic & Bariatric Surgery
  • (no location specified)
Sep 22, 2023

Myeloid-derived Suppressor Cells in Colorectal Cancer

Completed
  • Colorectal Cancer
  • +3 more
  • Level of Myeloid-Derived Suppressor Cells
  • Krakow, Malopolska, Poland
    1st Department of General Surgery
Jul 3, 2022

Systemic Lupus Erythematosus Trial in Vandoeuvre les nancy

Not yet recruiting
  • Systemic Lupus Erythematosus
    • Vandoeuvre les nancy, Lorraine, France
      Thomas Moulinet
    Jun 15, 2022

    Melanoma Trial in Milan (AEP Group Walking Sessions, CEP Group Walking Sessions)

    Recruiting
    • Melanoma
    • AEP Group Walking Sessions
    • CEP Group Walking Sessions
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Nov 8, 2022

    MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

    Not yet recruiting
    • Lung Neoplasms
    • +2 more
    • Tumor samples
    • Bordeaux, France
      CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
    Aug 28, 2023

    Myeloid-Derived Suppressor Cells in Sepsis

    Recruiting
    • Sepsis
    • Blood sampling
    • Gainesville, Florida
      UF Health at Shands hospital
    Jan 4, 2022

    Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte

    Recruiting
    • Hemophilia A
    • no intervention
    • Nantes, France
    • +1 more
    Jan 10, 2022

    Myeloid Derived Suppressor Cells Control by Signal Regulatory

    Completed
    • Hepatocellular Carcinoma
    • Collection of human samples
    • (no location specified)
    Sep 10, 2021

    Pathological Myeloid Activation After Sepsis and Trauma

    Recruiting
    • Trauma Injury
    • +3 more
    • Data Collection
    • +3 more
    • Gainesville, Florida
      UF Health at Shands Hospital
    Jan 19, 2023

    Glioblastoma Trial in Cleveland (Capecitabine, Bevacizumab)

    Active, not recruiting
    • Glioblastoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
    Feb 22, 2022

    Myeloid Derived Suppressor Cells Clinical Assay in Finding

    Recruiting
    • Healthy Subject
    • +5 more
    • Computed Tomography
    • +3 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 16, 2021

    Non Small Cell Lung Cancer Stage IIIB Trial in Philadelphia (Nivolumab, Nivolumab+Gemcitabine)

    Terminated
    Has Results
    • Non Small Cell Lung Cancer Stage IIIB
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Oct 6, 2020

    Chronic GVHD, Acute GVHD, Steroid Refractory GVHD Trial in Leuven, Liège (Rapamycin, T regulatory cells)

    Recruiting
    • Chronic Graft-Versus-Host Disease
    • +2 more
    • Leuven, Vlaams-Brabant, Belgium
    • +1 more
    Apr 27, 2021

    Metastatic Malignant Solid Tumor Trial in Columbus (drug, other, biological)

    Unknown status
    • Metastatic Malignant Solid Neoplasm
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 22, 2021

    Squamous Cell Carcinoma of the Oral Cavity Trial in Taipei (ß-glucan)

    Unknown status
    • Squamous Cell Carcinoma of the Oral Cavity
    • β-glucan
    • Taipei, Taiwan
      National Taiwan University Hospital
    May 10, 2020

    Advanced Solid Tumors (Part A/B/C/D), NSCLC (Part E), Melanoma (Part E) Trial in United States (IPI-549 (eganelisib), Nivolumab)

    Active, not recruiting
    • Advanced Solid Tumors (Part A/B/C/D)
    • +7 more
    • San Diego, California
    • +10 more
    Apr 1, 2022

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Tucson (Tadalafil 20 MG)

    Not yet recruiting
    • Gastric Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • Tadalafil 20 MG
    • Tucson, Arizona
      Arizona Cancer Center at UMC North/University Medical Center
    Feb 1, 2023

    Collection of Blood From Patients With Cancer

    Recruiting
    • Prostate Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Myeloid-Derived Suppressor Cell Function in Breast Cancer

      Recruiting
      • Breast Cancer
      • Specimen collection
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Feb 27, 2022

      Quantifying Systemic Immunosuppression to Personalize Cancer

      Recruiting
      • Melanoma
      • +6 more
      • MDSC quantification
      • Milan, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori
      Nov 11, 2022

      Metastatic Melanoma, Metastatic Breast Cancer, Advanced Renal Cell Carcinoma Trial in Worldwide (single arm)

      Withdrawn
      • Metastatic Melanoma
      • +5 more
      • single arm
      • (no location specified)
      Dec 20, 2022

      Breast Cancer, Breast Tumors Trial in Charlottesville (drug, device, other)

      Recruiting
      • Breast Cancer
      • Breast Neoplasms
      • Charlottesville, Virginia
        University of Virginia
      May 17, 2022

      Study on Initiation and Immunological Mechanism of Childbirth

      Recruiting
      • Pregnancy
        • Beijing, Beijing, China
          Beijing Ditan Hospital, Capital Medical University
        Oct 30, 2022

        Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

        Not yet recruiting
        • Chronic Myelomonocytic Leukemia
        • CD4CAR
        • Indianapolis, Indiana
          Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
        Oct 2, 2023

        Interleukins in Periodontal Disease Progression

        Recruiting
        • Periodontitis
        • Gingivitis
        • Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
        • Assiut, Asyut, Egypt
          Department of oral medicine, Periodontology, Oral diagnosis and
        Nov 16, 2023